VA Caps Hemp at 2 Milligrams. Next Year It’ll Sell 10.

Filed Under: Same THC, Different Door

---

Virginia is about to outlaw a three-milligram hemp gummy while preparing to license stores that can sell ten milligrams in a single serving.

Beginning August 15, hemp products produced or sold in the Commonwealth cannot contain more than two milligrams of total THC per package. Virginia is deleting the exception that allowed a higher amount when a product contained at least 25 parts CBD for every part THC.

Less than eleven months later, the adult-use cannabis market is scheduled to open. Licensed stores may sell edibles containing ten milligrams of THC per serving and one hundred milligrams per package.

According to the complaint reviewed by PCM, seven Virginia hemp businesses sued to stop the new limit. They say Virginia changed the rules beneath companies that built products around the old law while preparing a separate THC market where packages may contain fifty times more THC.

The dose does not change when it crosses the threshold. The law does.

Under the current hemp law, a product must remain at or below 0.3 percent total THC. A package may exceed 2 milligrams if it meets the 25:1 CBD ratio. That exception created a legal home for CBD-dominant products carrying modest amounts of THC. Low-dose edibles and tinctures were built around the rule.

The ratio disappears on August 15.

Testing will not save a package that exceeds the new limit. Neither will compliant labels or child-resistant packaging. A registered manufacturer may follow every rule Virginia imposed and still watch legal inventory become unsellable overnight.

Official guidance leaves no room for a softer reading. A product above two milligrams cannot be produced or sold as hemp after the deadline.

A three-milligram gummy gives the contradiction a body. The product can be legal today when paired with enough CBD. On August 15, it becomes unlawful at a hemp counter. Next July, that same dose will sit far below the limit inside a licensed cannabis store.

Virginia has not adopted one THC safety standard. It has adopted one rule for hemp sellers and another for cannabis licensees.

The Commonwealth already permits up to ten milligrams per dose in certain medical cannabis products. Adult-use stores will receive the same serving limit next year. Their packages may contain one hundred milligrams.

Virginia cannot credibly claim that two milligrams marks the point where THC becomes impossible to manage. The state already manages higher doses and plans to expand that access.

The real divide is the sales channel.

The complaint reviewed by PCM identifies the plaintiffs as NOVA Hemp LLC, District Hemp Botanicals, Cypress Hemp, Pure Shenandoah, Redfern Hemp Co., Kultivate, and Simply Hemp. The group reaches across Virginia’s hemp market, from production to retail.

Their complaint says the new limit destroys lawful inventory and strips value from operations built under a framework Virginia approved. The businesses also challenge the way the change became law.

The decisive language appeared in HB30, Virginia’s budget. It came through a conference report rather than a standalone hemp bill devoted to the two-milligram cap.

Conference reports arrive as completed packages. Lawmakers vote them up or down without rewriting individual provisions from the floor. A major commercial restriction entered law inside legislation the state had to pass.

Virginia can defend that method as ordinary legislative work. Courts rarely interfere with the General Assembly’s internal process. Budget bills also carry permanent policy far beyond taxes and spending.

That process deserves scrutiny because the consequence is not minor.

The Commonwealth is making many currently legal hemp products unsellable after August 15, yet the public never got a full hearing on the dose or the CBD ratio. Businesses caught beneath the rule never got an open fight over the policy threatening their product lines.

A restriction this blunt needs evidence, not a slogan.

No public record reviewed by PCM showed a Virginia study identifying two milligrams per package as a health threshold. The available materials did not explain why the state chose a package limit instead of a serving limit. They also failed to show why a product containing 2.1 milligrams becomes dangerous when the same state permits ten milligrams in medical cannabis.

Virginia may possess evidence for that choice. If public-health data drove the cap, the state should put that record before the public and connect it directly to the number lawmakers chose.

Until then, two milligrams looks less like a medical threshold than a market boundary.

The package rule makes the boundary harder to justify. A hemp producer can divide two milligrams into four tiny servings and reach the legal ceiling. A licensed cannabis company will be allowed to place ten servings of ten milligrams inside one package.

The hemp package stops at two. The cannabis package stops at one hundred.

Virginia can defend that fiftyfold difference by pointing to regulation. Licensed cannabis stores will operate inside a tighter system, where the state controls the supply chain more closely and requires testing before sale. Age limits and inventory tracking give that market safeguards hemp retailers do not always match.

That defense has a real basis.

The hemp market has earned scrutiny. Bad labels, unreliable potency claims, and candy-style packaging gave Virginia real problems to police.

Converted cannabinoids create another concern. A familiar chemical name tells a customer little about how the compound was produced. It tells even less about what remained after processing.

Congress did not force Virginia to accept reckless manufacturing or dishonest sales when it legalized hemp.

The Commonwealth already had tools to police those problems. Hemp businesses entered a system that required product registration and lab testing. It also demanded proper labels and child-resistant packaging where the law required it.

The new cap does not separate those operators from a seller moving mystery gummies under a fake laboratory report. Once the package crosses two milligrams, every other safeguard becomes irrelevant.

Virginia had narrower tools available. Bad lab work and unreliable potency claims could have faced tighter verification rules. Youth access could have been addressed without erasing compliant products. Child-appealing packaging needed direct enforcement, and converted cannabinoids needed separate treatment instead of being folded into a sweeping package cap.

Instead, the Commonwealth chose a number low enough to remove many intoxicating hemp products from ordinary retail commerce.

The result looks less like dose control than market control.

Hemp companies built products around the CBD ratio because Virginia told them that ratio was legal. That framework shaped inventory and product formulas. Equipment purchases followed, along with leases and payroll commitments. Supplier contracts remained tied to the old rule. Debt did too. The deadline does not erase those obligations.

Unsold inventory can lose its legal value in one day, but the bills attached to the business remain.

The plaintiffs describe those losses as an unconstitutional taking. Their complaint also raises due process and equal protection claims.

At the center of the case sits a simple accusation. Virginia created one legal standard for hemp businesses and another for the cannabis retailers it plans to license.

The lawsuit faces a steep road.

Virginia already defeated an earlier challenge to its hemp restrictions. In January 2025, the Fourth Circuit upheld the Commonwealth’s power to regulate hemp more tightly than federal law.

That ruling blocks the easiest argument. The new plaintiffs cannot point to the federal Farm Bill and declare their products untouchable.

Congress removed qualifying hemp from federal marijuana prohibition. It did not order every state to permit every hemp product on store shelves.

This case depends on a different injury. The businesses say they relied on Virginia’s own ratio exception before the state erased the framework that shaped their inventory and business value.

Reliance makes the case different. It does not guarantee a legal victory.

Courts give governments wide room to regulate products in the name of health and safety. A legal market does not come with a permanent promise that its rules will never change. Tighter standards can wipe value from inventory and weaken the licenses businesses once depended on.

If a judge accepts Virginia’s controlled-market rationale, the Commonwealth may win.

A legal win would not erase the contradiction. It would define it.

Virginia would be saying that three milligrams is acceptable inside one system and unacceptable inside another. The concern would not be the dose alone. It would be the state’s control over the seller.

That may be defensible policy. It is not proof that two milligrams protects public health.

The old CBD ratio was never sacred. CBD does not neutralize THC, and a product can satisfy the formula while still affecting the consumer.

Hemp businesses should not be allowed to hide intoxicating products behind soft wellness language simply because the package contains far more CBD.

Still, the ratio served a purpose in Virginia law. It distinguished CBD-dominant products from conventional THC edibles. It also limited how much THC could appear relative to the rest of the formula.

Lawmakers removed it without producing a public record PCM could find showing how the exception failed.

The timing makes the contradiction harder to ignore.

Virginia legalized adult possession in 2021 but refused to create a legal retail market. Adults could possess cannabis and grow a limited number of plants, yet they still had no normal place to buy tested recreational products.

For five years, the Commonwealth permitted possession while blocking commerce.

Hemp businesses moved into part of that vacuum. Traditional CBD remained, but hemp-derived THC products also found customers because adults had no adult-use dispensary available.

Those businesses did not create Virginia’s access failure. They operated inside it.

---

---

The state is now preparing to open the retail system it delayed for years. Adult-use sales are scheduled to begin July 1, 2027. Businesses holding cannabis licenses will gain the right to sell products that current hemp retailers cannot legally carry after August 15.

The new cap clears part of the field before those stores open.

No public document reviewed by PCM proves that a cannabis company wrote the rule. PCM did not find evidence that future dispensary operators purchased the change or received a promised protected market.

The advantage does not depend on a secret memo. It is visible in the law.

After August 15, a hemp retailer cannot sell a package containing more than two milligrams of total THC. Beginning next July, a licensed cannabis retailer can sell one containing one hundred milligrams.

Future license holders will not have to defeat those hemp products through price or quality. Virginia will have removed them through statute.

The coming cannabis market may not belong entirely to corporate giants. Virginia’s framework includes protections meant to support smaller operators and restrain consolidation.

Microbusiness opportunities could put licenses into local hands. Ownership limits may also keep a few national companies from swallowing the market on opening day.

That complicates any easy accusation of corporate capture.

The beneficiaries may include local entrepreneurs. Existing medical operators may seek a place in the adult-use system too.

Their size does not change the legal advantage.

A small cannabis retailer will be able to sell a ten-milligram serving while an established hemp shop across town faces penalties for selling three.

The chemistry remains the same. The permission changes.

Virginia has placed serious force behind that permission.

The Cannabis Control Authority is taking over hemp oversight and gaining broader enforcement power. A violation notice can become a stop-sale order, followed by civil penalties that reach $10,000 for each day a violation continues.

The state has also created 1-844-WEED-TIP so members of the public can report suspected illegal cannabis and hemp activity.

A retailer who leaves a three-milligram product on the shelf after August 15 will not be treated as someone caught in a technical transition. The business may be treated as an illegal seller.

Virginia is closing the door hard.

What happens to consumers during the next eleven months has received far less attention.

A person who currently buys a CBD-dominant gummy containing three or five milligrams of THC will lose that option before a replacement market opens. Virginia appears to be betting that those consumers will wait, seek medical access, or stop buying.

That is a weak bet.

The market Virginia removes from legal stores may reappear online or through informal sellers, where testing and labels can be worse than the registered hemp products removed from shelves.

Virginia could create a public-health gap in the name of public health.

The Commonwealth has lived through this mistake already. Legal possession began in 2021, but retail access remained unresolved for years. That failure left much of adult-use demand outside a licensed retail system.

Now Virginia is repeating the sequence on a smaller scale by eliminating a legal THC source before the approved replacement is ready. If the adult-use launch slips, the gap will last even longer while hemp stores remain bound by the two-milligram rule.

Virginia’s record offers no reason to assume every deadline will hold. The state took years to move from legal possession toward retail access. Building a new licensing system will not happen because the calendar says so.

A structured transition could reduce the damage. Virginia could have let registered businesses sell through inventory bought under the old law. It could have built a temporary path for clean operators into the adult-use system. That would have preserved oversight while the new market took shape.

Virginia chose a harder break.

Existing operators now face bad choices. Reformulation may preserve a product while killing the effect customers bought it for. Leaving Virginia means losing the local market. Chasing a cannabis license takes time, money, and luck. Abandoning the affected products means surrendering the investment already tied to them.

Officials may believe that hardship is justified. Governments regularly sacrifice existing businesses when they build stricter systems. Public policy does not owe every company survival.

The justification still needs to match the damage.

Virginia should say plainly whether it wants every meaningful THC product confined to the Cannabis Control Authority’s licensed market. Such a policy would be severe, but at least the public could debate the real decision.

Calling the cap a simple potency safeguard hides what it does.

The rule decides who may sell THC and under which license. It pushes demand away from hemp retailers before adult-use stores open. Higher doses become the property of businesses admitted into Virginia’s preferred system.

That is not a minor side effect. It is the structure of the law.

The Cannabis Control Authority is assembling a public-health advisory system for adult-use cannabis. That process gives experts a visible place to debate risk before the new market opens.

PCM found no comparable public examination of the hemp cap in the materials reviewed. A conference report erased the CBD exception. The same language set the deadline and expanded regulatory power without the visible debate a major health policy deserved.

---

---

Virginia could still fill the record. Officials should put the health analysis behind the two-milligram limit in public view, explain why the cap applies to a full package, and identify the incidents that convinced lawmakers the old rule had failed.

Until that happens, the policy speaks through its consequences.

A legal hemp business loses the right to sell a three-milligram package. A future cannabis retailer gains the right to sell one hundred milligrams.

The THC is the same. The doorway changes, and so does the punishment.

The lawsuit may fail because Virginia has broad power to regulate hemp. A court could reject the taking claim or accept the state’s argument that licensed cannabis stores provide enough oversight to justify higher product limits.

Virginia could win every legal argument and still lose the public one.

Authority does not make a policy coherent.

The state has not shown that two milligrams marks the point where a hemp product becomes dangerous. It has shown that two milligrams marks the point where a hemp business loses the sale.

Next year, a licensed cannabis store will be trusted with five times that amount in one serving and fifty times that amount in a package.

Virginia has not banned the dose.
It has chosen the dealer.

---

_{^{©2026, Pot Culture Magazine. All rights reserved. This is the property of Pot Culture Magazine and is protected by U.S. and international copyright laws.
Unauthorized reproduction, distribution, or transmission of this work, in part or in whole, without the express
written permission of Pot Culture Magazine is strictly prohibited.}}

---